Anebulo Pharmaceuticals, Inc. (ANEB)
NASDAQ: ANEB · Real-Time Price · USD
1.260
-0.140 (-10.00%)
Feb 21, 2025, 4:00 PM EST - Market closed
Anebulo Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
| Net Income | -7.67 | -8.2 | -11.73 | -6.83 | -30.25 | -1.05 |
| Other Amortization | 0.24 | 0.15 | - | - | - | - |
| Stock-Based Compensation | 1.18 | 0.76 | 0.88 | 0.48 | 0.2 | - |
| Other Operating Activities | - | - | - | - | 26.63 | 0.01 |
| Change in Accounts Receivable | - | - | - | - | 0 | - |
| Change in Accounts Payable | -0.04 | -0.38 | 0.15 | 0.27 | 0.11 | - |
| Change in Other Net Operating Assets | -0.36 | -0.42 | 1.01 | 0.64 | -1.56 | 0.14 |
| Operating Cash Flow | -6.65 | -8.09 | -9.68 | -5.44 | -4.87 | -0.9 |
| Total Debt Issued | - | - | - | - | - | 1.2 |
| Short-Term Debt Repaid | - | - | - | - | -0.2 | - |
| Total Debt Repaid | - | - | - | - | -0.2 | - |
| Net Debt Issued (Repaid) | - | - | - | - | -0.2 | 1.2 |
| Issuance of Common Stock | 15 | - | 6.7 | - | 20.6 | - |
| Other Financing Activities | - | -0.06 | -0.32 | - | 1.43 | -0.15 |
| Financing Cash Flow | 15 | -0.06 | 6.38 | - | 21.83 | 19.05 |
| Net Cash Flow | 8.35 | -8.15 | -3.3 | -5.44 | 16.96 | 18.15 |
| Free Cash Flow | -6.65 | -8.09 | -9.68 | -5.44 | -4.87 | -0.9 |
| Free Cash Flow Per Share | -0.25 | -0.31 | -0.39 | -0.23 | -0.36 | -0.08 |
| Cash Interest Paid | - | - | - | - | 0.01 | - |
| Levered Free Cash Flow | -4.09 | -5.18 | -5.32 | -2.88 | -3.51 | - |
| Unlevered Free Cash Flow | -4.18 | -5.23 | -5.32 | -2.88 | -3.5 | - |
| Change in Net Working Capital | 0.36 | 0.8 | -1.16 | -0.91 | 1.45 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.